Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia

Blood Cancer Journal

Volumn 2, Issue 3, 2012, Pages

  Iacobucci, I ^a   Ferrarini, A ^b   Sazzini, M ^a   Giacomelli, E ^b   Lonetti, A ^a   Xumerle, L ^b   Ferrari, A ^a   Papayannidis, C ^a   Malerba, G ^b   Luiselli, D ^a   Boattini, A ^a   Garagnani, P ^a   Vitale, A ^c   Soverini, S ^a   Pane, F ^d   Baccarani, M ^a   Delledonne, M ^b   Martinelli, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ALL; BCR ABL1; Sequencing

Indexed keywords

BCR ABL PROTEIN; COMPLEMENTARY DNA; TRANSCRIPTOME;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CASE REPORT; CATALYSIS; CELL CYCLE REGULATION; DNA SEQUENCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; MALE; MISSENSE MUTATION; PHILADELPHIA CHROMOSOME POSITIVE CELL; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84860839390     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2012.6     Document Type: Article

References (41)

1. Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 1960; 25: 85-109.
2. Rowley JD. Acquired trisomy 9. Lancet 1973; 2: 390.
3. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93-99. (Pubitemid 14155374)
4. Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R et al. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 1987; 325: 635-637. (Pubitemid 17055688)
5. Xiao Z, Ray M, Jiang C, Clark AB, Rogozin IB, Diaz M. Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias. Mol Immunol 2007; 44: 2659-2666. (Pubitemid 46240319)
6. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375-2384. (Pubitemid 26327486)
7. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110-114. (Pubitemid 351630327)
8. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360: 470-480.
9. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008; 5: 621-628. (Pubitemid 351911867)
10. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulkner GJ, Brown MK et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods 2008; 5: 613-619. (Pubitemid 351911866)
11. Li H, Lovci MT, Kwon YS, Rosenfeld MG, Fu XD, Yeo GW. Determination of tag density required for digital transcriptome analysis: application to an androgensensitive prostate cancer model. Proc Natl Acad Sci U S A 2008; 105: 20179-20184.
12. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, Scherf M et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008; 321: 956-960.
13. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008; 456: 66-72.
14. Soverini S, Iacobucci I, Baccarani M, Martinelli G. Targeted therapy and the T315I mutation in Philadelphia-positive leukemias. Haematologica 2007; 92: 437-439. (Pubitemid 350144288)
15. Pricl S, Fermeglia M, Ferrone M, Tamborini E. T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study. Mol Cancer Ther 2005; 4: 1167-1174. (Pubitemid 41149564)
16. Yamamoto M, Kurosu T, Kakihana K, Mizuchi D, Miura O. The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase. Biochem Biophys Res Commun 2004; 319: 1272-1275. (Pubitemid 38759547)
17. Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ et al. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res 2008; 36: 6535-6547.
18. Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E et al. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. Blood 2008; 112: 3847-3855.
19. Mullighan C, Downing J. Ikaros and acute leukemia. Leuk Lymphoma 2008; 49: 847-849. (Pubitemid 351942735)
20. Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 2009; 27: 5202-5207.
21. Bullard JH, Purdom EA, Hansen KD, Durinck S, Dudoit S. Statistical inference in mRNASeq: exploratory data analysis and differential expression. UC Berkeley Division of Biostatistics Working Paper Series 2009; 247.
22. Fielding A. The treatment of adults with acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2008, 381-389.
23. Ottmann OG, Wassmann B. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2005, 118-122.
24. Telegeev GD, Dubrovska AN, Dybkov MV, Maliuta SS. Influence of BCR/ABL fusion proteins on the course of Ph leukemias. Acta Biochim Pol 2004; 51: 845-849. (Pubitemid 39296937)
25. Irizarry RA, Warren D, Spencer F, Kim IF, Biswal S, Frank BC et al. Multiplelaboratory comparison of microarray platforms. Nat Methods 2005; 2: 345-350.
26. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008; 18: 1509-1517.
27. Lloret M, Lara PC, Bordon E, Fontes F, Rey A, Pinar B et al. Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and bax downregulation in cervical carcinoma tumors. Int J Radiat Oncol Biol Phys 2009; 73: 976-979.
28. Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M. Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies. J Pediatr Surg 2009; 44: 377-380.
29. Lee E, Lim SJ. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines. Arch Pharm Res 2006; 29: 1018-1023. (Pubitemid 44885780)
30. Mossink MH, van Zon A, Scheper RJ, Sonneveld P, Wiemer EA. Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 2003; 22: 7458-7467. (Pubitemid 37487169)
31. Nakagawa H, Inazawa J, Inoue K, Misawa S, Kashima K, Adachi H et al. Assignment of the human renal dipeptidase gene (DPEP1) to band q24 of chromosome 16. Cytogenet Cell Genet 1992; 59: 258-260.
32. Nicolini FE, Mauro MJ, Martinelli G, Kim DW, Soverini S, Muller MC et al. Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation. Blood 2009; 114: 5271-5278.
33. Palmer D, Jimmo SL, Raymond DR, Wilson LS, Carter RL, Maurice DH. Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation. J Biol Chem 2007; 282: 9411-9419. (Pubitemid 47104617)
34. Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD et al. Alternative expression analysis by RNA sequencing. Nat Methods 2010; 7: 843-847.
35. Au KF, Jiang H, Lin L, Xing Y, Wong WH. Detection of splice junctions from paired-end RNA-seq data by SpliceMap. Nucleic Acids Res 2010; 38: 4570-4578.
36. Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010; 26: 873-881.
37. Ameur A, Wetterbom A, Feuk L, Gyllensten U. Global and unbiased detection of splice junctions from RNA-seq data. Genome Biol 2010; 11: R34.
38. Robertson G, Schein J, Chiu R, Corbett R, Field M, Jackman SD et al. De novo assembly and analysis of RNA-seq data. Nat Methods 2010; 7: 909-912.
39. Sboner A, Habegger L, Pflueger D, Terry S, Chen DZ, Rozowsky JS et al. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNAsequencing data. Genome Biol 2010; 11: R104.
40. Kinsella M, Harismendy O, Nakano M, Frazer KA, Bafna V. Sensitive gene fusion detection using ambiguously mapping RNA-Seq read pairs. Bioinformatics 2011; 27: 1068-1075.
41. Li Y, Chien J, Smith DI, Ma J. FusionHunter: identifying fusion transcripts in cancer using paired-end RNA-seq. Bioinformatics 2011; 27: 1708-1710.